Results indicate that both MS-275 and VPA induces NIS expression in breast and hepatocellular carcinoma cell lines, whereas MS-275-mediated induction of endogenous NIS expression is absent in lung cancer, ovarian cancer, and glioblastoma cell lines. The gene discussed is SLC5A5; the disease is hepatocellular carcinoma.